Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • June 9, 2023
  • Article
  • New England Journal of Medicine

A Radical Treatment for Insulin Pricing

By: Leemore S. Dafny
  • Format:Print
ShareBar

Abstract

In 2021, the Food and Drug Administration (FDA) approved the first interchangeable biosimilar for long-acting insulin, which many hoped would be substantially cheaper than the reference branded product. I explain why prices have barely changed, and argue that a regulatory or disruptive business fix is needed to bring down insulin prices. I describe one promising fix on the horizon: the announcement by a nonprofit firm, CivicaRx, to manufacture and sell its own interchangeable biosimilars, bypassing the traditional supply chain.

Keywords

Biosimilars; Rebates; Pharmaceuticals; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; United States

Citation

Dafny, Leemore S. "A Radical Treatment for Insulin Pricing." New England Journal of Medicine 386, no. 23 (June 9, 2023): 2157–2159.
  • Find it at Harvard
  • Register to Read

About The Author

Leemore S. Dafny

General Management
→More Publications

More from the Author

    • August 10, 2023
    • Promarket

    A Conversation on the Draft Merger Guidelines

    By: Cory S. Capps and Leemore Dafny
    • Summer 2023
    • American Journal of Health Economics

    Do Policies to Increase Access to Treatment for Opioid Use Disorder Work?

    By: Eric Barrette, Leemore S. Dafny and Karen Shen
    • April 20, 2023
    • NEJM.org

    Falling Insulin Prices—What Just Happened?

    By: Leemore S. Dafny
More from the Author
  • A Conversation on the Draft Merger Guidelines By: Cory S. Capps and Leemore Dafny
  • Do Policies to Increase Access to Treatment for Opioid Use Disorder Work? By: Eric Barrette, Leemore S. Dafny and Karen Shen
  • Falling Insulin Prices—What Just Happened? By: Leemore S. Dafny
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College